Manuscript submission
There are no charges for publication in this journal and all manuscripts should be submitted via journal URL: http://irjnm.tums.ac.ir
Conditions and Ethics
Manuscripts are considered with the understanding that they are submitted solely to the "Iran J Nucl Med" and have not been published elsewhere previously either in print or electronic format, and are not under consideration by another publication or electronic medium. Submission of an article for publication implies the transfer of the copyright from the authors to the "Iran J Nucl Med" upon acceptance. The final decision of acceptance rests with the Editor. Authors are responsible for all statements made in their papers. All accepted papers become the permanent property of the "Iran J Nucl Med" and you may not modify copy, distribute, transmit, display, or publish elsewhere without written permission from the "Iran J Nucl Med". Authors should refrain from contacting the mass media about papers that are being peer reviewed or in press; the Editor reserves the right to withdraw an article from publication if it is given media coverage at any stage of the review/publication process.
Ethical considerations will be taken into account in the assessment of papers that have experimental investigations of human or animal subjects. Authors should state in the Methods section of the manuscript that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors and an appropriate institutional review board approved the project. Those investigators without such review boards should ensure that the principles outlined in the Declaration of Helsinki have been followed.
Manuscript categories
Original articles
These include controlled trials, interventional studies, studies of screening and diagnostic tests, outcome studies, cost-effectiveness analyses, and large-scale epidemiological studies. Each manuscript should clearly state an objective; the design and methodology; the essential features of any interventions; the main outcome measures; the main results of the study; a discussion placing the results in the context of published literature; and the conclusions which can be drawn based on the study. The text should not exceed 4000 words, the number of tables, figures, or both should not be more than six, and references not more than 40.
Review articles
These are, in general, invited papers, but unsolicited reviews, if of good quality, may be considered. Reviews are systematic critical assessments of literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. The text should not exceed 6000 words, the number of tables, figures, or both should not be more than ten, and references not more than 120. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and test or outcomes. All articles and data sources should be selected systematically for inclusion in the review and critically evaluated, and the selection process should also be described in the paper.
Case reports
Case reports will be accepted only if they deal with a clinical problem that is of sufficient interest. The text should not exceed 2500 words; the number of tables, figures, or both should not be more than four; references should not be more than 25.
Editorials/Commentaries
Commentaries on current topics or on papers published elsewhere in the issue. Length should not exceed 2000 words; tables or figures are allowed only exceptionally; references should not be more than 40.
Letters to the Editor
Letters discussing a recent article in the "Iran J Nucl Med" are welcome and should be sent to the Editorial Office by e-mail <irjnm@sina.tums.ac.ir> within 6 weeks of the article’s publication. Letters that do not refer to an "Iran J Nucl Med" article may also be considered. The text should not exceed 1000 words, have no more than two figure or table, and 10 references.
Criteria for manuscripts
Manuscripts submitted to the "Iran J Nucl Med" should meet the following criteria: the content is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data; the information is important; and the topic has general medical interest. Manuscripts will be accepted only if both their contents and style meet the standards required by the "Iran J Nucl Med".
Manuscript preparation
Authors should refer to a current issue of the "Iran J Nucl Med" and to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals for guidance on style. Use Arabic numerals for numbers above nine, for designators (e.g. case 5, day 2, etc) and for units of measure; numbers should be spelled out if below 10, at the beginning of sentences, and for fractions below one. Manuscripts should be word-processed double-spaced.
The manuscript (complete with tables and figures) should be submitted via journal URL: http://irjnm.tums.ac.ir
The manuscript should be accompanied by the following statements, signed by all the authors: "No work resembling the enclosed article has been published or is being submitted for publication elsewhere. We certify that we have each made a substantial contribution so as to qualify for authorship and that we have approved the contents. We have disclosed all financial support for our work and other potential conflicts of interests." Use System International (SI) measurements only, except when "Dual report" is indicated in the SI unit conversion table. Use generic names of drugs, unless the specific trade name of a drug used is directly relevant to the discussion. When generic names are not available, brand names which take an initial capital can be used. In Original articles, the maker of the study drug must be given. Do not use abbreviations and symbols in the title or abstract and limit their use in the text. Standard abbreviations may be used and should be defined on first mention in the text unless they are the standard units of measurement. In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader.
Peer review and publication processes: All manuscripts are considered to be confidential. They are peer reviewed by at least 2 anonymous reviewers selected by the Editorial Board. The corresponding author is notified as soon as possible of the editor decision to accept, reject, or require modifications. If the manuscript is completely acceptable according to the criteria set forth in these instructions, it is scheduled for the next available issue. A computer print out is sent to the corresponding author for proof reading before publication in order to avoid any mistakes. Corrections should be marked clearly and sent immediately to the journal office. The corresponding author will be supplied with 2 free issues. Once published, all copies of the manuscript, correspondence and artwork will be held for 6 months before disposal.
Arrangement
Title page-This page should contain (1) the title, (2) names and surnames of authors, with their degrees [maximum two] and affiliations; if an author's affiliation has changed since the work was done, list the new affiliation as well, (3) the full address, phone and fax numbers, and e-mail address of the corresponding author, and (4) a short running head of no more than 40 characters.
Abstract-The abstract should not exceed 250 words for structured (Original articles, Review articles) unstructured abstracts (Case reports). The abstract should be concise, summarizing the purpose, basic procedures, main findings (giving specific data and their statistical significance, if possible), and principal conclusions of the investigation. Abstract headings should be as follows: Objective, Design, Setting, Patients (or Participants), Interventions (if any), Main outcome measures, Results, and Conclusions (for Original articles); Objective, Data sources, Study selection, Data extraction, Data synthesis, and Conclusions (for Review articles); or Objective, Participants, Evidence, Consensus Process, and Conclusions (for Consensus statements).
Key words-At the end of the abstract, authors should provide no more than five key words to assist with cross-indexing of the paper. Key words should be taken from Medical Subject Headings (MeSH) list of Index Medicus (http://www.nlm.nih.gov/mesh/MBrowser.html).
Introduction-The rationale for the study should be summarized and pertinent background material outlined. The Introduction should not include findings or conclusions.
Methods-These should be described in sufficient detail to leave the reader in no doubt as to how the results are derived.
Results-These should be presented in logical sequence in the text, tables, and illustrations; repetitive presentation of the same data in different forms should be avoided. This section should not include material appropriate to the Discussion. Results must be statistically analyzed where appropriate, and the statistical guidelines of the International Committee of Medical Journal Editors should be followed.
Discussion-Data given in the Results section should not be repeated here. This section should consider the results in relation to any hypothesis/es advanced in the Introduction. This may include an evaluation of methodology and of the relationship of new information to the existing body of knowledge in that field. Conclusions should be incorporated into the final paragraph and should be commensurate with-and completely supported by-data in the text.
Acknowledgement-All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. It should include persons who provided technical help, writing assistance and departmental head who only provided general support. Financial and material support should be acknowledged.
References-Number references in the order they appear in the text; do not alphabetize. References should follow the Vancouver style and should appear in the text, tables, and legends as Arabic numerals in parenthesis. Journal titles should be abbreviated in accordance with Index Medicus. Authors are responsible for the accuracy of references and must verify them against the original documents.
The following are sample references:
Standard journal article
List all authors when there are six or fewer; when there are seven or more, list the first six, then "et al" :
Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ et al. Paraoxonase and coronary heart disease. Curr Opin Lipidol. 1998 Aug;9(4):319-24.
As an option, the month and issue number may be omitted.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
Article, no author given:
Cancer in South Africa. S Afr Med J. 1994 Dec;84(12):15.
Chapter in a book:
Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.
Book, personal author(s):
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996.
Book, editor(s) as author:
Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.
Book, Organization as author and publisher:
Institute of Medicine (US). Looking at the future of the Medicaid program. Washington: The Institute; 1992.
Article in electronic form:
Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5];1(1):[24 screens]. Available from: URL: http://www.cdc.gov/ncidod/EID/eid.htm
Conference proceedings:
Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.
Conference paper :
Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland.
Tables and figures
Tables
Do not submit tables as photographs. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory matter in footnotes, not in the heading.
All non-standard abbreviations used in each table should be defined in the footnotes, in alphabetical order. Statistical measures of variations such as standard deviation, standard error of the mean, or confidence interval should be identified in headings. Vertical rules and horizontal rules should be omitted. Ensure that each table is cited in the text.
Figures
Illustrations include photographs, photomicrographs, charts, and diagrams, and these should be camera-ready. Professional medical illustrators should be consulted when figures are prepared; freehand or typewritten lettering is unacceptable. Letters, numbers, and symbols should be clear and of sufficient size to retain legibility when reduced. The diagram should not lose clarity on reduction; it is generally simplest to aim for a 50% linear reduction. Titles and detailed explanations should be confined to legends and not included in illustrations. Number illustrations consecutively in the order of their first citation in the text. Photographs of persons must be retouched to make the subject unidentifiable, and be accompanied by written permission from the subject to use the photograph.
The Final Checklist
The authors must ensure that before submitting the manuscript for publication, they have taken care of the following:
1- Title page should contain title, short running title, name and surname of author/co-authors, their qualifications, designation and institutions they are affiliated with and mailing address for future correspondence, e-mail address, phone and fax number.
2- Abstract in structured format up to 250 words.
3- References mentioned as stated in the Instruction to Authors section.
4- Do not submit tables as photographs. Make sure for heading of the table, their number.
5- Photographs/illustrations along with their captions. Titles and detailed explanations should be confined to legends and not included in illustrations.
6- Disclosure regarding source of funding and conflict of interest if any besides approval of the study from respective Ethics Committee/Institution Review Board.
7- Covering Letter
8- Copyright Transfer Form
Sample Cover Letter
Dear Editor
On behalf of my co-authors, I would like to submit our manuscript entitled “--------------------------------” for consideration of publication by your Journal. This manuscript has not been published in this or any similar form (in print or electronically, including on a web site), nor accepted for publication elsewhere, nor is under consideration by another publication. All authors offer the copyright to the "Iran J Nucl Med" and each author has contributed significantly to the submitted manuscript. Also it should be mentioned that, there is no conflict of interest in connection with the submitted article.
"Corresponding Author's Signature"
Copyright Transfer Form
The Iranian Journal of Nuclear Medicine is pleased to publish your manuscript # , entitled:
"-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------"
Upon acceptance by The Iranian Journal of Nuclear Medicine, all copyright ownership for the article named above is transferred to The Iranian Journal of Nuclear Medicine. We, the undersigned coauthors of this article, have contributed to (1) data design, analysis, or interpretation; (2) writing or critiquing drafts of the manuscript; and (3) approval of the final manuscript before publication. We share in the responsibility for the release of any part or all of the material contained within the article noted above. We also affirm that the manuscript has been seen and approved by all authors. The undersigned stipulate that the material submitted to The Iranian Journal of Nuclear Medicine is new, original and has not been submitted to another publication, be it print or electronic, for concurrent consideration; likewise, this manuscript has not been published elsewhere either in part or in its entirety.
We also attest that any human and/or animal studies undertaken as part of the research from which this manuscript was derived are in compliance with regulations of our institution(s) and with generally accepted guidelines governing such work.
We further attest that we have herein disclosed any and all financial or other relationships that could be construed as a conflict of interest and that all sources of financial support for this study have been disclosed and are indicated in the acknowledgments.
Corresponding Author’s Signature Date
Author’s Signature Date
Author’s Signature Date
Author’s Signature Date
Author’s Signature Date
Author’s Signature Date
Author’s Signature Date
Author’s Signature Date
Author’s Signature Date